These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 9448766
1. Inflammatory pseudotumor of the liver: MRI with mangafodipir trisodium. Materne R, Van Beers BE, Gigot JF, Horsmans Y, Lacrosse M, Pringot J. J Comput Assist Tomogr; 1998; 22(1):82-4. PubMed ID: 9448766 [Abstract] [Full Text] [Related]
2. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Wang C. Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956 [Abstract] [Full Text] [Related]
3. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Lee VS, Krinsky GA, Nazzaro CA, Chang JS, Babb JS, Lin JC, Morgan GR, Teperman LW. Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606 [Abstract] [Full Text] [Related]
4. Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. Mortelé KJ, Wiesner W, de Hemptinne B, Elewaut A, Praet M, Ros PR. Eur Radiol; 2002 Feb; 12(2):304-8. PubMed ID: 11870426 [Abstract] [Full Text] [Related]
5. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Karabacakoğlu A, Adigüzel Y, Karaköse S, Kayaçetin E, Haykir R. Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248 [Abstract] [Full Text] [Related]
6. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs. Jung G, Heindel W, Krahe T, Kugel H, Walter C, Fischbach R, Klaus H, Lackner K. Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775 [Abstract] [Full Text] [Related]
7. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks]. Assaban M, Aubé C, Lebigot J, Ridereau-Zins C, Hamy A, Caron C. J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779 [Abstract] [Full Text] [Related]
8. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. Scharitzer M, Schima W, Schober E, Reimer P, Helmberger TK, Holzknecht N, Stadler A, Ba-Ssalamah A, Weber M, Wrba F. J Comput Assist Tomogr; 2005 Jan; 29(2):181-90. PubMed ID: 15772534 [Abstract] [Full Text] [Related]
9. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. Kim SK, Kim SH, Lee WJ, Kim H, Seo JW, Choi D, Lim HK, Lee SJ, Lim JH. AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056 [Abstract] [Full Text] [Related]
10. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Coffin CM, Diche T, Mahfouz A, Alexandre M, Caseiro-Alves F, Rahmouni A, Vasile N, Mathieu D. Eur Radiol; 1999 Sep; 9(3):444-9. PubMed ID: 10087113 [Abstract] [Full Text] [Related]
11. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. Sahani DV, O'Malley ME, Bhat S, Hahn PF, Saini S. J Comput Assist Tomogr; 2002 Sep; 26(2):216-22. PubMed ID: 11884777 [Abstract] [Full Text] [Related]
12. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? Chung JJ, Kim MJ, Kim KW. J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954 [Abstract] [Full Text] [Related]
13. Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features. Chezmar JL, Redvanly RD, Sewell CW. Acad Radiol; 1996 Aug; 3 Suppl 2():S413-4. PubMed ID: 8796617 [No Abstract] [Full Text] [Related]
14. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. Kim HJ, Kim KW, Byun JH, Won HJ, Shin YM, Kim PN, Lee MS, Lee MG. AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579 [Abstract] [Full Text] [Related]
16. Mangafodipir trisodium: effects on T2- and T1-weighted MR cholangiography. Mitchell DG, Alam F. J Magn Reson Imaging; 1999 Feb; 9(2):366-8. PubMed ID: 10077039 [Abstract] [Full Text] [Related]
17. Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging. Savellano DH, Köstler H, Baus S, Mössinger M, Gratz KF, Weimann A, Galanski M. Invest Radiol; 2004 May; 39(5):305-12. PubMed ID: 15087726 [Abstract] [Full Text] [Related]
18. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. Romijn MG, Stoker J, van Eijck CH, van Muiswinkel JM, Torres CG, Laméris JS. J Magn Reson Imaging; 2000 Aug; 12(2):261-8. PubMed ID: 10931589 [Abstract] [Full Text] [Related]
19. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. Sahani DV, Kalva SP, Fischman AJ, Kadavigere R, Blake M, Hahn PF, Saini S. AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430 [Abstract] [Full Text] [Related]
20. Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium. Koh DM, Brown G, Meer Z, Norman AR, Husband JE. AJR Am J Roentgenol; 2007 Feb; 188(2):W154-61. PubMed ID: 17242222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]